Falls Church, VA (PRWEB) September 07, 2017
Drug and device marketers and corporate counsel need to know what ads can and cannot say.
August T. Horvath Esq. has a list. And he’s sharing it.
In more than 20 years defending false-advertising clients, leading antitrust lawyer, Mr. Horvath has discovered an alarmingly high percentage of TV viewers come away with false impressions of what ads claim are true. Usually these false impressions overstate efficacy, and miss or understate side effects.
But false impressions can lead to real legal problems with the FDA, with the FTC, with states and municipalities, and with private lawsuits.
This webinar will spell out what manufacturers can do to prevent false impressions. Topics covered include:
- How misleading impressions occur, including why viewers misinterpret efficacy claims
- How to list side effects to avoid misinterpretation
- How to head off FDA or FTC actions against alleged unsubstantiated medical and comparison claims
- Proven techniques for substantiating claims
- And much more
This webinar goes beyond just regulatory and legal responsibility with real-life scenarios of advertising gone awry. Why risk false-claim actions that could cost millions, not to mention a manufacturer’s reputation? Register today.
Meet the Presenter:
August T. Horvath Esq., an antitrust partner at Kelley Drye, has 20 years’ experience defending drug and device makers against false-advertising claims. His work has taken him to the courts, the Federal Trade Commission (FTC) and other state and federal agencies, as well as the Council of Better Business Bureaus and other interested parties. Clients say they value his ability to apply complex law to everyday scenarios, as well as to formulate logical arguments based upon objective facts and sound legal theory.
Who Will Benefit:
- Corporate counsel
- Outside counsel
- Regulatory Affairs
- Commercial Operations
- Medical Affairs
Advertising Medical Products:
Real-Life Scenarios that Illustrate What You Can and Cannot Say
**An FDAnews Webinar**
Sept. 19, 2017 — 1:30 p.m. – 3:00 p.m. ET
$287 per site
Easy Ways to Register:
By phone: 888-838-5578 or 703-538-7600
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.